CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX)

26 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q1 2024.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.16M shares of 15M outstanding shares and own 14.45% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (543K shares), VANGUARD GROUP INC (374K shares), DIMENSIONAL FUND ADVISORS LP (358K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (287K shares), ACADIAN ASSET MANAGEMENT LLC (188K shares), BlackRock Inc. (111K shares), GEODE CAPITAL MANAGEMENT, LLC (84.5K shares), Bank of New York Mellon Corp (75.3K shares), STATE STREET CORP (33.7K shares), and TWO SIGMA INVESTMENTS, LP (32.4K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.